Tricosanoic acid

Identification

Generic Name
Tricosanoic acid
DrugBank Accession Number
DB03500
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 354.6101
Monoisotopic: 354.349780716
Chemical Formula
C23H46O2
Synonyms
  • n-Tricosanoic acid

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
ULipase 3Not AvailableYeast
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms.
Kingdom
Organic compounds
Super Class
Lipids and lipid-like molecules
Class
Fatty Acyls
Sub Class
Fatty acids and conjugates
Direct Parent
Very long-chain fatty acids
Alternative Parents
Straight chain fatty acids / Monocarboxylic acids and derivatives / Carboxylic acids / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
Substituents
Aliphatic acyclic compound / Carbonyl group / Carboxylic acid / Carboxylic acid derivative / Hydrocarbon derivative / Monocarboxylic acid or derivatives / Organic oxide / Organic oxygen compound / Organooxygen compound / Straight chain fatty acid
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
very long-chain fatty acid, straight-chain saturated fatty acid (CHEBI:42394) / Straight chain fatty acids (LMFA01010023)
Affected organisms
Not Available

Chemical Identifiers

UNII
MUC9A0MS6V
CAS number
2433-96-7
InChI Key
XEZVDURJDFGERA-UHFFFAOYSA-N
InChI
InChI=1S/C23H46O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23(24)25/h2-22H2,1H3,(H,24,25)
IUPAC Name
tricosanoic acid
SMILES
CCCCCCCCCCCCCCCCCCCCCCC(O)=O

References

General References
Not Available
Human Metabolome Database
HMDB0001160
PubChem Compound
17085
PubChem Substance
46507803
ChemSpider
16170
ChEBI
42394
ChEMBL
CHEMBL1173462
ZINC
ZINC000006920379
PDBe Ligand
F23
Wikipedia
Tricosylic_acid
PDB Entries
1llf / 7xhu

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility2.57e-05 mg/mLALOGPS
logP9.39ALOGPS
logP9.37Chemaxon
logS-7.1ALOGPS
pKa (Strongest Acidic)4.95Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area37.3 Å2Chemaxon
Rotatable Bond Count21Chemaxon
Refractivity109.29 m3·mol-1Chemaxon
Polarizability49.4 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9888
Blood Brain Barrier+0.9488
Caco-2 permeable+0.8326
P-glycoprotein substrateNon-substrate0.6321
P-glycoprotein inhibitor INon-inhibitor0.9598
P-glycoprotein inhibitor IINon-inhibitor0.9277
Renal organic cation transporterNon-inhibitor0.9266
CYP450 2C9 substrateNon-substrate0.7886
CYP450 2D6 substrateNon-substrate0.8956
CYP450 3A4 substrateNon-substrate0.6982
CYP450 1A2 substrateInhibitor0.8326
CYP450 2C9 inhibitorNon-inhibitor0.8808
CYP450 2D6 inhibitorNon-inhibitor0.9554
CYP450 2C19 inhibitorNon-inhibitor0.9578
CYP450 3A4 inhibitorNon-inhibitor0.9484
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9647
Ames testNon AMES toxic0.9865
CarcinogenicityNon-carcinogens0.6452
BiodegradationReady biodegradable0.8795
Rat acute toxicity1.3275 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9322
hERG inhibition (predictor II)Non-inhibitor0.8868
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MS (1 TMS)GC-MSsplash10-0159-2900000000-90925cf3c5c344889a87
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0006-8790000000-189d993955590b247b04
GC-MS Spectrum - GC-MSGC-MSsplash10-0159-2900000000-90925cf3c5c344889a87
Mass Spectrum (Electron Ionization)MSsplash10-0596-9201000000-4c4b474aedf9d85a53e1
MS/MS Spectrum - Quattro_QQQ 10V, PositiveLC-MS/MSsplash10-0pvr-0298000000-80b9daf5924525f32b70
MS/MS Spectrum - Quattro_QQQ 25V, PositiveLC-MS/MSsplash10-00di-3390000000-ac935102623d865e251d
MS/MS Spectrum - Quattro_QQQ 40V, PositiveLC-MS/MSsplash10-00l6-4980000000-ff160222688e5c3a5eba
MS/MS Spectrum - ESI-TOF 40V, NegativeLC-MS/MSsplash10-014i-0090000000-1e57778151b8b2a05362
MS/MS Spectrum - ESI-TOF 30V, NegativeLC-MS/MSsplash10-014i-0090000000-1e57778151b8b2a05362
MS/MS Spectrum - ESI-TOF 10V, NegativeLC-MS/MSsplash10-014i-0090000000-1e57778151b8b2a05362
MS/MS Spectrum - ESI-TOF 20V, NegativeLC-MS/MSsplash10-014i-0090000000-1e57778151b8b2a05362
MS/MS Spectrum - ESI-TOF , NegativeLC-MS/MSsplash10-014i-0090000000-1e57778151b8b2a05362
MS/MS Spectrum - ESI-TOF 40V, NegativeLC-MS/MSsplash10-014i-0090000000-1e57778151b8b2a05362
MS/MS Spectrum - ESI-TOF 30V, NegativeLC-MS/MSsplash10-014i-0090000000-1e57778151b8b2a05362
MS/MS Spectrum - ESI-TOF 10V, NegativeLC-MS/MSsplash10-014i-0090000000-1e57778151b8b2a05362
MS/MS Spectrum - ESI-TOF 20V, NegativeLC-MS/MSsplash10-014i-0090000000-1e57778151b8b2a05362
MS/MS Spectrum - ESI-TOF , NegativeLC-MS/MSsplash10-014i-0090000000-1e57778151b8b2a05362
MS/MS Spectrum - ESI-TOF 40V, NegativeLC-MS/MSsplash10-05fr-0590000000-455d8ab1313a61d90f8c
MS/MS Spectrum - ESI-TOF 30V, NegativeLC-MS/MSsplash10-0udi-0009000000-6cab4a327eae32b5f787
MS/MS Spectrum - ESI-TOF 10V, NegativeLC-MS/MSsplash10-0udi-0029000000-37d069e8e40dc2126055
MS/MS Spectrum - ESI-TOF 20V, NegativeLC-MS/MSsplash10-0udi-0009000000-32d4687abf7d5b474472
MS/MS Spectrum - ESI-TOF , NegativeLC-MS/MSsplash10-0udi-0009000000-0756d3aa19109128f075
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-05fr-0590000000-455d8ab1313a61d90f8c
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-0udi-0009000000-6cab4a327eae32b5f787
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-0udi-0029000000-37d069e8e40dc2126055
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-0udi-0009000000-32d4687abf7d5b474472
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-05n0-3119000000-4147dc3942fa150b05d4
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0udi-0009000000-aa1432a240dd4ec920d9
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0udi-0009000000-0aa79f24a12b68d19c8c
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-05n3-9366000000-1b577de4c761097efad8
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9122000000-6127d07c4cc67484a829
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-052f-9200000000-ede953a768ecc8929a88
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-240.0204004
predicted
DarkChem Lite v0.1.0
[M-H]-239.7306004
predicted
DarkChem Lite v0.1.0
[M-H]-239.5120004
predicted
DarkChem Lite v0.1.0
[M-H]-186.28749
predicted
DeepCCS 1.0 (2019)
[M+H]+190.30716
predicted
DeepCCS 1.0 (2019)
[M+Na]+199.12222
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Yeast
Pharmacological action
Unknown
General Function
Triglyceride lipase activity
Specific Function
Not Available
Gene Name
LIP3
Uniprot ID
P32947
Uniprot Name
Lipase 3
Molecular Weight
58754.18 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52